A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Company | Founded & HQ | Stage / Raised to Date from | Description | Product Category | |||||||||||||||||||||
2 | BiomeSense | 2018 Chicago | $10M incl. IndieBio, Bluestein Ventures | Developing novel technologies to enable continuous, at-home monitoring of the human microbiome. | Microbiome enabling technology | |||||||||||||||||||||
3 | Clinical Microbiomics | 2016 CPH | $10M Seventure | We help you decode the genetic and metabolic fingerprints of our microbial inhabitants to address our most urgent health challenges. | Microbiome enabling technology | |||||||||||||||||||||
4 | PhenoAI | 2021 Tel Aviv | n/a Entrée Capital | Developer of a database platform designed to provide deep-phenotype multi-omics datasets. | Microbiome enabling technology | |||||||||||||||||||||
5 | Cryptobiotix | 2021 Belgium | n/a | Provider of next-gen preclinical CRO in the gastrointestinal space intended to offer in vitro digestion and ex vivo gut microbiome research services. | Microbiome enabling technology | |||||||||||||||||||||
6 | Holobiome | 2015 incorporated - 2017 operational kick-off - Boston | Seed - $2M dilutive capital | The human gut microbiome company (”The answer was inside us all along.”) | The human gut microbiome company (”The answer was inside us all along.”) | |||||||||||||||||||||
7 | Genbioma | 2019 Spain | n/a | Microbiome company dedicated to making people healthier through microbiome-targeted solutions. | Microbiome therapeutics - pharma and consumer (probiotic supplement for prediabetics) | |||||||||||||||||||||
8 | Kallyope | 2015 NYC | Bill & Melinda Gates Foundation | Aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. | Microbiome therapeutics - pharma (neuro, metabolism, GI) | |||||||||||||||||||||
9 | Axial Biotherapeutics | 2016 US | $110M incl. Seventure, Kairos Ventures | Clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System. | Microbiome therapeutics - pharma (gut<>brain focus) | |||||||||||||||||||||
10 | Kaleido Biosciences | 2015 US | $217 incl. Olive Tree Capital, liquidated in 2022 | Focused on leveraging the potential of the microbiome organ to treat disease and improve human health. | Microbiome therapeutics - pharma | |||||||||||||||||||||
11 | PharmaBiome | 2015 Zurich Switzerland | CHF 2M | Technologies to access the entire range of intestinal bacteria for the design and production of function-based consortia at scale. | Microbiome therapeutics - pharma | |||||||||||||||||||||
12 | AsiaBiome | 2018 US / HK | $0.15M before being acquired by Holobiome in 2022 | Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics. | Microbiome therapeutics - pharma | |||||||||||||||||||||
13 | Finch Therapeutics | 2017 MA US | $188M before going public in March 2021 | Microbiome development company that serve patients with serious unmet medical needs. | Microbiome therapeutics - pharma | |||||||||||||||||||||
14 | Maat Pharma | 2014 France | €31M incl. Seventure | Clinical-stage microbiome therapeutics company aiming to improve survival in cancer | Microbiome therapeutics - pharma (oncology) | |||||||||||||||||||||
15 | Microbiotica | 2016 Cambridge UK | GBP 26M incl. Tencent, Seventure | Developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers | Microbiome therapeutics - pharma | |||||||||||||||||||||
16 | Enterome | 2012 France | €175M incl. Nestlé, Seventure | Clinical stage cancer treatments. | Microbiome therapeutics - pharma | |||||||||||||||||||||
17 | Seres Therapeutics | 2010 MA US | $527M incl. Mayo Clinic, Nestlé (now public) | Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. | Microbiome therapeutics - pharma | |||||||||||||||||||||
18 | Vedanta Biosciences | 2010 MA US | $433 incl. Pfizer | A New Class of Drugs to Modulate the Human Microbiome | Microbiome therapeutics - pharma | |||||||||||||||||||||
19 | Evelo Biosciences | 2014 MA US | Liquidated Nov. 2023 | Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine. | Microbiome therapeutics - pharma | |||||||||||||||||||||
20 | Azitra | 2014 US | $37M incl. Leaps by Bayer (now public) | Precision dermatology powered by microbial and genetic engineering. | Microbiome therapeutics - pharma (skin) | |||||||||||||||||||||
21 | AOBiome | 2013 MA US | $105M incl. Wild Ventures | Live topical biotherapeutics for the treatment of inflammatory skin disorders. | Microbiome therapeutics - pharma (skin) | |||||||||||||||||||||
22 | SNIPR Biome | 2017 CPH | $53M incl. EQT Lifesciences, Wellington Partnera | We are pioneering CRISPR-based microbial gene therapy. | Microbiome therapeutics - pharma | |||||||||||||||||||||
23 | BiomX Inc. | 2015 Israel | $81M incl. Seventure (now public) | Customized phage therapies to eradicate harmful bacteria in chronic diseases. | Microbiome therapeutics - pharma | |||||||||||||||||||||
24 | Eligo Bioscience | 2014 Paris | $69M incl. Sanofi, Khosla, Seventure | Gene-editing focused on addressing diseases driven by the expression of bacterial genes from the microbiome. | Microbiome therapeutics - pharma | |||||||||||||||||||||
25 | Ombre | 2016 SF | n/a | Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
26 | DayTwo | 2015 California | $90M incl. J&J, MayoClinic, Seventure, Cathay Innovation, Samsung Next | Precision nutrition for metabolic disease using gut microbiome science, AI and virtual clinical support. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
27 | Viome | 2016 Washington | $210 incl. Bulletproof Media, Squareone Capital | Operator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
28 | Zoe | 2017 London | $107M incl. Balderton, Ahren Innovation, Daphni | Provider of medical testing services intended to deliver recommendations on personalized dietary plans for individuals. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
29 | Biomes | 2017 Germany, Mexico | Raised $8M, liquidated in 2022 | Manufacturer of probiotics and tests designed to improve individual life through precision nutrition & health prevention. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
30 | Microba | 2017 Australia | Public (ASX:MAP) | Commercial-stage company with technology for measuring the human gut microbiome | Microbiome insights / Health Test Providers | |||||||||||||||||||||
31 | Floré | 2016 San Diego | $27M incl. IndieBio, Plug and Play, Pngaea Ventures | Provider of gut test and custom probiotics intended for improving gut health. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
32 | Biohm Health | 2016 US | $8M incl. Aztec Capital | Manufacturer of gut health products and kits intended to help people understand their gut microbiome. | Microbiome insights / Health Test Providers | |||||||||||||||||||||
33 | TargEDys | 2015 France | $10M Seventure, Pontifax | Developer of microbe mechanism designed to control the metabolic disease by modulating the appetite through intervention. | Food & biopharma | |||||||||||||||||||||
34 | OneBio | 2019 Sacramento | $17M iSelect, Seventure, Collab Fund | one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. | Food & biopharma | |||||||||||||||||||||
35 | Siolta Therapeutics | 2016 California | $30M incl. GlobalBrain, Marc Benioff, Seventure, Khosla | Clinical-stage biopharmaceutical company developing novel targeted live biotherapeutic products (LBPs) to prevent and treat diseases of high unmet medical need. | Food & biopharma | |||||||||||||||||||||
36 | Akkermansia Company | 2016 Belgium | $19M incl. Seventure | Developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium | Food & biopharma | |||||||||||||||||||||
37 | Seed Health | 2015 LA | $43M incl. Collab. Fund, 8VC, Founders Fund, Greycroft | Developer of health supplements intended to implement applications of bacteria to impact human and environmental health. | Probiotic Providers | |||||||||||||||||||||
38 | Immune Biotech | 2013 Sweden | $2.7M incl. EU and Hampus Jakobsson (GP Pale Blue Dot) | Developer of novel therapeutics designed to target the gut microbiota and the immune system. | Probiotic Providers | |||||||||||||||||||||
39 | Resbiotic | 2020 Birmingham | $2.6M incl. First Avenue Ventures | Developer of probiotic therapies intended to restore a healthy lung microbiome. | Probiotic Providers | |||||||||||||||||||||
40 | Fitbiomics | 2015 NY | $4.5M incl. Builders VC | Developer of a novel probiotic bacteria biotechnology designed to be used for sports performance and recovery. | Probiotic Providers | |||||||||||||||||||||
41 | MYBACS | 2018 Munich, Germany | $5.9M incl. WENVEST, GFC, Joyance Partners | Synbiotic dietary supplements, personalized and adapted to the different needs of the customers while being gluten-free, lactose-free and free of any chemical side effects. | Probiotic Providers | |||||||||||||||||||||
42 | Unlocked | 2020 US | $0.5M incl. IndieBio, Astanor | Developer of a probiotic supplement designed to help people detox their bodies. | Probiotic Providers | |||||||||||||||||||||
43 | Pendulum | 2013 SF | $122M incl. Khosla, Sequoia, DCVC, Mayo Clinic | Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackling type 2 diabetes. | Probiotic Providers | |||||||||||||||||||||
44 | Isovive | 2013 US | $12.6 incl. Plug and Play, Alumni Ventures | Developer of microbiome products intended to support human gut health. | Probiotic Providers | |||||||||||||||||||||
45 | Nouri | 2018 US | >$0.5M EY Ventures Group | Producer of probiotic supplements intended to improve gut health and also offer benefits to the body in specific ways. | Probiotic Providers | |||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |